Recent Updates
Recently added Catalysts
IDYA

IDEAYA Biosciences Appoints Douglas B Snyder as Senior Vice President, General Counsel

Key Takeaway: IDEAYA Biosciences Appoints Douglas B Snyder as Senior Vice President, General Counsel
Price reaction · baseline $35.78 (2024-09-17 close) · hit after-hours · 4 other IDYA headline(s) in the window, move may be shared
day 0 close · peak
-2.9%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma

Full Press Release Details

IDEAYA Biosciences Appoints Douglas B Snyder as Senior Vice President, General Counsel.
Last updated: Sep 18, 2024